Zobrazeno 1 - 10
of 121
pro vyhledávání: '"David Piccioni"'
Autor:
Priya U. Kumthekar, Barbara Blouw, Perry Corkos, Seema Nagpal, Arushi Tripathy, David Piccioni, Michael Youssef
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionCNSide is a platform that detects and characterizes tumor cells in the cerebrospinal fluid (CSF) of patients with leptomeningeal disease (LMD). The platform was validated per College of American Pathologists (CAP) and Clinical Laboratorie
Externí odkaz:
https://doaj.org/article/a4602abf11c5492b932f0f10399332db
Autor:
Gabriel Nistor, Robert Dillman, Daniela Bota, David Piccioni, Christopher Duma, Renato LaRocca, Santosh Kesari, Jose Carrillo, Robert Aiken, Frank Hsu, Thomas Taylor, Mehrdad Abedi, Xiaotang Kong, Candace Hsieh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/880199fb78a646b7bc992874e012370a
Autor:
Gabriel Nistor, Robert Dillman, Daniela Bota, David Piccioni, Christopher Duma, Renato LaRocca, Santosh Kesari, Jose Carrillo, Robert Aiken, Frank Hsu, Xiao-Tang Kong, Thomas Taylor, Mehrdad Abedi, Candace Hsieh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/8f9a84d2159c4de8b1710c03af1984ef
Autor:
Gabriel Nistor, Robert Dillman, Aleksandra Poole, Daniela Bota, David Piccioni, Christopher Duma, Renato LaRocca, Santosh Kesari, Jose Carrillo, Robert Aiken, Frank Hsu, Xiao-Tang Kong, Thomas Taylor, Mehrdad Abedi, Candace Hsieh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/cb2068f08fb04b3f882fb1d7137e7e73
Autor:
Gabriel Nistor, Robert Dillman, Daniela Bota, David Piccioni, Christopher Duma, Renato LaRocca, Santosh Kesari, Jose Carrillo, Robert O’Donnell, Robert Aiken, Frank Hsu, Xiao-Tang Kong, Thomas Taylor
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/8cd04fc55fb04915a14b7c36cb3b604c
Autor:
Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-9 (2018)
Abstract Background Standard therapy for glioblastoma includes surgery, radiotherapy, and temozolomide. This Phase 3 trial evaluates the addition of an autologous tumor lysate-pulsed dendritic cell vaccine (DCVax®-L) to standard therapy for newly di
Externí odkaz:
https://doaj.org/article/7b4a8b2c7d344b0e9344d197a7338b0a
Autor:
Linda M. Liau, Keyoumars Ashkan, David D. Tran, Jian L. Campian, John E. Trusheim, Charles S. Cobbs, Jason A. Heth, Michael Salacz, Sarah Taylor, Stacy D. D’Andre, Fabio M. Iwamoto, Edward J. Dropcho, Yaron A. Moshel, Kevin A. Walter, Clement P. Pillainayagam, Robert Aiken, Rekha Chaudhary, Samuel A. Goldlust, Daniela A. Bota, Paul Duic, Jai Grewal, Heinrich Elinzano, Steven A. Toms, Kevin O. Lillehei, Tom Mikkelsen, Tobias Walbert, Steven R. Abram, Andrew J. Brenner, Steven Brem, Matthew G. Ewend, Simon Khagi, Jana Portnow, Lyndon J. Kim, William G. Loudon, Reid C. Thompson, David E. Avigan, Karen L. Fink, Francois J. Geoffroy, Scott Lindhorst, Jose Lutzky, Andrew E. Sloan, Gabriele Schackert, Dietmar Krex, Hans-Jorg Meisel, Julian Wu, Raphael P. Davis, Christopher Duma, Arnold B. Etame, David Mathieu, Santosh Kesari, David Piccioni, Manfred Westphal, David S. Baskin, Pamela Z. New, Michel Lacroix, Sven-Axel May, Timothy J. Pluard, Victor Tse, Richard M. Green, John L. Villano, Michael Pearlman, Kevin Petrecca, Michael Schulder, Lynne P. Taylor, Anthony E. Maida, Robert M. Prins, Timothy F. Cloughesy, Paul Mulholland, Marnix L. Bosch
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss 1, Pp 1-2 (2018)
Following publication of the original article [1], the authors reported an error in the spelling of one of the author names. In this Correction the incorrect and correct author names are indicated and the author name has been updated in the original
Externí odkaz:
https://doaj.org/article/523386e861dd4740aa938b4e7fa9768c
Publikováno v:
BMJ case reports, vol 16, iss 3
Autoimmune glial fibrillar acidic protein (GFAP) astrocytopathy is a rare autoimmune neuroinflammatory disorder that affects the central nervous system. We present a case of GFAP astrocytopathy in a middle-aged male who presented with constitutional
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cb1ac0f5566b0f02ce772461298ac88
https://escholarship.org/uc/item/8hc1b10b
https://escholarship.org/uc/item/8hc1b10b
Autor:
Michael Chan, Steven Tatter, Veronica Chiang, Peter Fecci, Roy Strowd, Sujit Prabhu, Constantinos Hadjipanayis, John Kirkpatrick, David Sun, Kaylyn Sinicrope, Alireza M Mohammadi, Parag Sevak, Steven Abram, Albert H Kim, Eric Leuthardt, Samuel Chao, John Phillips, Michel Lacroix, Brian Williams, Dimitris Placantonakis, Joshua Silverman, James Baumgartner, David Piccioni, Adrian Laxton
Publikováno v:
Neuro-oncology advances, vol 5, iss 1
Background Laser interstitial thermal therapy (LITT) in the setting of post-SRS radiation necrosis (RN) for patients with brain metastases has growing evidence for efficacy. However, questions remain regarding hospitalization, local control, symptom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b50ac6c18b1e4bdf78bf2cf41832b6a
https://escholarship.org/uc/item/7qs244c3
https://escholarship.org/uc/item/7qs244c3
Autor:
John de Groot, Albert Kim, Sujit Prabhu, Ganesh Rao, Adrian Laxton, Peter Fecci, Barbara O'Brien, Andrew Sloan, Veronica Chiang, Stephen Tatter, Alireza Mohammadi, Dimitris Placantonakis, Roy Strowd, Clark Chen, Constantinos Hadjipanayis, Mustafa Khasraw, David Sun, David Piccioni, Kaylyn Sinicrope, Jian Campian, Sylvia Kurz, Brian Williams, Kris Smith, Zulma Tovar-Spinoza, Eric Leuthardt
Publikováno v:
Neuro-Oncology. 24:vii256-vii257
Treatment options for glioblastoma remain limited, particularly for those who are not eligible for traditional resection, whether due to lesion location or inability to tolerate open craniotomy. Maximal-safe resection followed by radiation with concu